OTCMKTS:ULUR

ULURU (ULUR) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
6,691 shs
Market Capitalization
$5.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ULUR stock logo

About ULURU Stock (OTCMKTS:ULUR)

ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. was founded in 1987 and is based in Addison, Texas.

ULUR Stock News Headlines

Tourist films snake digging deep hole in Uluru
Automatic Income (from home)
For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year.
Automatic Income (from home)
For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year.
Where to See Kangaroo in Australia
The cost of marrying a British prince
See More Headlines
Receive ULUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ULURU and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ULUR
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
30,237,000
Market Cap
$5.35 million
Optionable
Not Optionable
Beta
-3.13
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Ms. Vaidehi A. Shah (Age 47)
    Chairman & CEO
    Comp: $101.88k
  • Mr. Anish Vithaldas Shah (Age 57)
    VP & Director
  • Ms. Oksana V. Tiedt (Age 48)
    VP of Clinical & International Affairs and Director
  • Mr. P. K Ramachandran (Age 70)
    Chief Financial Officer

ULUR Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ULURU own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ULURU investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Jaguar Health (JAGX).

How do I buy shares of ULURU?

Shares of ULUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ULUR) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners